Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

POTENTIAL MULTIBAGGER

Do You Own this Little-known Smallcap Stock? >> READ MORE

List of Diagnostics Stocks 

Here are the latest stock price details of India's top Diagnostics stocks. For more detailed updates, check the latest Diagnostics sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
DR. LAL PATHLABS 2,170.00 -0.12% 2,174.00 0.16%
 More Info 
KRSNAA DIAGNOSTICS 539.15 0.06% 532.00 -1.57%
 More Info 
METROPOLIS HEALTHCARE 1,405.00 -2.26% 1,415.00 -1.61%
 More Info 
NIFTY 50 Not Listed 15,783.35 -0.42%
 More Info 
S&P BSE SENSEX 53,026.97 -0.28% Not Listed
 More Info 
THYROCARE TECHNOLOGIES 625.00 -0.99% 629.00 -0.38%
 More Info 
VIJAYA DIAGNOSTIC 338.90 1.76% 337.20 1.37%
 More Info 

BSE prices: June 29, 2022  03:32:00 PM    NSE prices: June 29, 2022  3:29:59 PM

Diagnostics Stocks Update

Within the Diagnostics sector, the top gainers were VIJAYA DIAGNOSTIC (up 1.8%) and KRSNAA DIAGNOSTICS (up 0.1%). On the other hand, METROPOLIS HEALTHCARE (down 2.3%) and THYROCARE TECHNOLOGIES (down 1.0%) were among the top losers.

Meanwhile, the benchmark S&P BSE SENSEX was at 53,027.0 (down 0.3%).


What else is happening in the markets today? Dig in...


Today's Market

Sensex Ends 150 Points Lower, Nifty Falls Below 15,800; FMCG & Banking Stocks Witness Selling(Closing)

After opening deep in the red, Indian share markets recovered most of the losses as the session progressed but still ended on a negative note.

Related Views on News

DR. LAL PATHLABS 2021-22 Annual Report Analysis (Annual Result Update)

Jun 14, 2022

Here's an analysis of the annual report of DR. LAL PATHLABS for 2021-22. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the valuation of DR. LAL PATHLABS.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. LAL PATHLABS SHARE PRICE


Jun 29, 2022 03:32 PM

TRACK DR. LAL PATHLABS

  • Track your investment in DR. LAL PATHLABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. LAL PATHLABS

DR. LAL PATHLABS 8-QTR ANALYSIS

COMPARE DR. LAL PATHLABS WITH

MARKET STATS